Scholarlink

<p>The gold standard treatment for renal cell carcinoma with a tumor thrombus (RCC-TT) is radical nephrectomy with tumor thrombectomy (RN-TT). Operative approaches to this can be done open (ORN-TT), laparoscopic (LRN-TT), or robotic (RRN-TT). The purpose of this study was to compare overall survival (OS), cancer-specific survival (CSS), and metastasis-free survival (MFS) between open, laparoscopic, and robotic approaches to RN-TT using the Intercontinental Collaboration on Renal Cell Carcinoma (ICORCC) database. Patient records were reviewed from the ICORCC database. All patients included in the study underwent RN-TT for RCC-TT from 1999 to present. Tumor thrombus level was graded using the Neves classification system. Statistical analysis was carried out using analysis of variance, chi-squared test, and Kaplan–Meier survival curves with log-rank test to compare outcomes by surgical approach. A total of 392 patients were included. There were 308 ORN-TT, 61 LRN-TT, and 23 RRN-TT cases. On Kaplan–Meier analysis, OS and CSS were not significantly different by approach (<i>p</i> &gt; 0.05). MFS was significantly lower in RRN-TT patients (<i>p</i> = 0.030). Operative time was the longest in ORN-TT, followed by LRN-TT, and RRN-TT the quickest (<i>p</i> = 0.011). Blood transfusion rates were significantly lower in RRN-TT relative to ORN-TT (<i>p</i> &lt; 0.001). Rates of lymph node dissection, soft tissue margin positivity, and cytoreductive surgery were alike (<i>p</i> &gt; 0.05). There is no definitive superiority of one operative approach compared to another. RRN-TT may result in worse MFS for patients, which calls for further investigation, but this is not certain. Ultimately, the risks, benefits, and resources the surgeon has at his/her disposal should all play in the final operative choice of RN-TT for the patient.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A comparison of open, laparoscopic, and robotic radical nephrectomy with tumor thrombectomy from the intercontinental collaboration on renal cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月4日

查看全文
  • Maxwell Sandberg,
  • Gregory Russell,
  • Jacob Malakismail,
  • Mitchell Hayes,
  • Reuben Ben David,
  • Justin Miller,
  • Kartik Patel,
  • Brejjette Aljabi,
  • Seok-Soon Byun,
  • Oscar Rodriguez Faba,
  • Donato Cannoletta,
  • Tatiana Letowski,
  • Gustavo Villoldo,
  • Patricio Garcia Marchinena,
  • Thiago Mourao,
  • Gaetano Ciancio,
  • Charles C. Peyton,
  • Rafael Zanotti,
  • Philippe E. Spiess,
  • Reza Mehrazin,
  • Diego Abreu,
  • Stenio de Cassio Zequi,
  • Alejandro Rodriguez

摘要

The gold standard treatment for renal cell carcinoma with a tumor thrombus (RCC-TT) is radical nephrectomy with tumor thrombectomy (RN-TT). Operative approaches to this can be done open (ORN-TT), laparoscopic (LRN-TT), or robotic (RRN-TT). The purpose of this study was to compare overall survival (OS), cancer-specific survival (CSS), and metastasis-free survival (MFS) between open, laparoscopic, and robotic approaches to RN-TT using the Intercontinental Collaboration on Renal Cell Carcinoma (ICORCC) database. Patient records were reviewed from the ICORCC database. All patients included in the study underwent RN-TT for RCC-TT from 1999 to present. Tumor thrombus level was graded using the Neves classification system. Statistical analysis was carried out using analysis of variance, chi-squared test, and Kaplan–Meier survival curves with log-rank test to compare outcomes by surgical approach. A total of 392 patients were included. There were 308 ORN-TT, 61 LRN-TT, and 23 RRN-TT cases. On Kaplan–Meier analysis, OS and CSS were not significantly different by approach (p > 0.05). MFS was significantly lower in RRN-TT patients (p = 0.030). Operative time was the longest in ORN-TT, followed by LRN-TT, and RRN-TT the quickest (p = 0.011). Blood transfusion rates were significantly lower in RRN-TT relative to ORN-TT (p < 0.001). Rates of lymph node dissection, soft tissue margin positivity, and cytoreductive surgery were alike (p > 0.05). There is no definitive superiority of one operative approach compared to another. RRN-TT may result in worse MFS for patients, which calls for further investigation, but this is not certain. Ultimately, the risks, benefits, and resources the surgeon has at his/her disposal should all play in the final operative choice of RN-TT for the patient.